MicroVention, a Terumo subsidiary, today announced its official rebranding to Terumo Neuro, effective immediately. The company says the name change signifies a new chapter in its evolution while maintaining its commitment to neurovascular care. Aliso Viejo, California-based Microvention — founded in 1997 and acquired by Terumo in 2006 — develops a number of technologies for […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The top 10 neurotech stories of the year so far
+ 7 neurotech companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ 7 brain-computer interface companies you need to know
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
Neuromod tech developer Neuspera appoints first COO
Neuspera Medical announced today that it appointed Bunty Banerjee as its first chief operating officer (COO). The San Jose, California-based sacral neuromodulation (SNM) technology developer said Banerjee will lead activities in R&D and operations while working closely with all other functions. His appointment comes as the company completes a new FDA submission for its neuromodulation […]
Zeto inks partnership with Firefly Neuroscience
Zeto has formed a partnership with Firefly Neuroscience that boosts the distribution of Zeto’s FDA-cleared EEG headset devices. The strategic partnership, announced yesterday, makes Buffalo, New York–based Firefly a non-exclusive distributor of Santa Clara, California–based Zeto’s headset. The collaboration also includes the integration of Firefly’s proprietary Brain Network Analytics (BNA) technology with the EEG platforms, […]
Hinge Health unveils new FDA-cleared wireless pain relief device
Hinge Health announced that it launched its Enso 3 FDA-cleared wireless device for reducing musculoskeletal pain. San Francisco-based Hinge designed the device to deliver electrical nerve stimulation for non-invasive, non-addictive pain relief within minutes. The company plans to start the first shipments of the new Enso device this month. It then expects wider availability to […]
NeuroOne touts breakthrough case with neuroablation system
NeuroOne Medical Technologies (Nasdaq:NMTC) today announced a breakthrough patient procedure using its OneRF ablation system. The OneRF system picked up FDA 510(k) clearance in December 2023 for the creation of radiofrequency (RF) lesions in nervous tissue for functional neurosurgical procedures. This technology uses already-implanted sEEG electrodes to record brain activity and enable the ablation of […]
Neurostim company Phagenesis picks new CEO
Phagenesis, a developer of neurostimulation for treating swallowing dysfunction announced today that it appointed Chad Hoskins as CEO. A seasoned executive, Hoskins brings decades of experience scaling therapies, driving U.S. growth and delivering on strategic objectives. He joins the company around six months after it raised $42 million in a Series D financing round. The […]
NeuroPace adds former Boston Scientific DBS marketing head, former Magnus Medical CEO as VPs
NeuroPace (Nasdaq:NPCE) announced today that it appointed Brett Wingeier as its new VP of R&D and Katie Keller as VP of marketing. Both appointments made by the maker of the FDA-approved RNS system for treating epilepsy go into effect immediately. Wingeier’s experience includes a stint as co-founder, CTO and CEO of Magnus Medical, another neurostimulation […]
Abbott initiates study of deep-brain stimulation for treatment-resistant depression
Abbott announced today that it initiated a pivotal clinical trial evaluating its deep-brain stimulation (DBS) system in the treatment of depression. The TRANSCEND study looks at DBS in the management of treatment-resistant depression (TRD), a form of major depressive disorder. Abbott won FDA breakthrough device designation to explore the use of DBS for TRD more […]
CVRx adds two new faces to its board as long-serving member departs
CVRx (Nasdaq:CVRX) announced today that it appointed Kevin Ballinger and Mitch Hill to its board of directors, effective immediately. “We are thrilled to welcome Kevin and Mitch to our Board of Directors,” said Kevin Hykes, President and CEO of CVRx. “Their extensive experience in the medical device industry, coupled with their strong track records driving […]
Onward receives $1.1M Christopher & Dana Reeve Foundation grant to expand BCI study
Onward Medical announced today that it received a grant from the Christopher & Dana Reeve Foundation to support an ongoing study. The $1.1 million grant supports the expansion of an ongoing early clinical feasibility study of the use of the company’s brain-computer interface (BCI). Onward’s study evaluates the use of BCI to restore thought-driven use […]
Another 5 brain-computer interface companies you should know
Over the past several months, there have been a number of significant developments in the brain-computer interface (BCI) space. The likes of Neuralink, Synchron and Precision Neuroscience, among others, continue to advance their platforms. Some even began clinical trials, while many more companies are vying to be the first to bring a BCI to market. […]
